Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Association of COVID-19 Vaccination With Symptomatic SARS-CoV-2 Infection by Time Since Vaccination and Delta Variant Predominance
Amadea Britton, Katherine E. Fleming-Dutra, Nong Shang, et al.
JAMA (2022) Vol. 327, Iss. 11, pp. 1032-1032
Open Access | Times Cited: 81

Showing 1-25 of 81 citing articles:

Effectiveness of COVID-19 vaccines against SARS-CoV-2 variants of concern: a systematic review and meta-analysis
Baoqi Zeng, Le Gao, Qingxin Zhou, et al.
BMC Medicine (2022) Vol. 20, Iss. 1
Open Access | Times Cited: 234
Long-term effectiveness of COVID-19 vaccines against infections, hospitalisations, and mortality in adults: findings from a rapid living systematic evidence synthesis and meta-analysis up to December, 2022
Nana Wu, Keven Joyal‐Desmarais, Paula Aver Bretanha Ribeiro, et al.
The Lancet Respiratory Medicine (2023) Vol. 11, Iss. 5, pp. 439-452
Open Access | Times Cited: 187
Effectiveness of COVID-19 Pfizer-BioNTech BNT162b2 mRNA Vaccination in Preventing COVID-19–Associated Emergency Department and Urgent Care Encounters and Hospitalizations Among Nonimmunocompromised Children and Adolescents Aged 5–17 Years — VISION Network, 10 States, April 2021–January 2022
Nicola P. Klein, Melissa S. Stockwell, Maria Demarco, et al.
MMWR Morbidity and Mortality Weekly Report (2022) Vol. 71, Iss. 9, pp. 352-358
Open Access | Times Cited: 170
Effectiveness of mRNA Vaccination in Preventing COVID-19–Associated Invasive Mechanical Ventilation and Death — United States, March 2021–January 2022
Mark W. Tenforde, Wesley H. Self, Manjusha Gaglani, et al.
MMWR Morbidity and Mortality Weekly Report (2022) Vol. 71, Iss. 12, pp. 459-465
Open Access | Times Cited: 159
Association of Prior BNT162b2 COVID-19 Vaccination With Symptomatic SARS-CoV-2 Infection in Children and Adolescents During Omicron Predominance
Katherine E. Fleming-Dutra, Amadea Britton, Nong Shang, et al.
JAMA (2022) Vol. 327, Iss. 22, pp. 2210-2210
Open Access | Times Cited: 139
Incidence of Severe COVID-19 Illness Following Vaccination and Booster With BNT162b2, mRNA-1273, and Ad26.COV2.S Vaccines
J. Daniel Kelly, Samuel Leonard, Katherine J. Hoggatt, et al.
JAMA (2022) Vol. 328, Iss. 14, pp. 1427-1427
Open Access | Times Cited: 59
Immunogenicity, effectiveness, and safety of COVID-19 vaccines among children and adolescents aged 2–18 years: an updated systematic review and meta-analysis
Peng Gao, Liangyu Kang, Jue Liu, et al.
World Journal of Pediatrics (2023) Vol. 19, Iss. 11, pp. 1041-1054
Open Access | Times Cited: 21
Association Between Vaccination Status and Mortality Among Intubated Patients With COVID-19–Related Acute Respiratory Distress Syndrome
Eirini Grapsa, Georgios Adamos, Ioannis Andrianopoulos, et al.
JAMA Network Open (2022) Vol. 5, Iss. 10, pp. e2235219-e2235219
Open Access | Times Cited: 35
Effectiveness of mRNA-1273, BNT162b2, and BBIBP-CorV vaccines against infection and mortality in children in Argentina, during predominance of delta and omicron covid-19 variants: test negative, case-control study
Juan Manuel Castelli, Analía Rearte, Santiago Olszevicki, et al.
BMJ (2022), pp. e073070-e073070
Open Access | Times Cited: 29
Passive infusion of an S2-Stem broadly neutralizing antibody protects against SARS-CoV-2 infection and lower airway inflammation in rhesus macaques
Christopher T Edwards, Kirti A. Karunakaran, Elijah Garcia, et al.
PLoS Pathogens (2025) Vol. 21, Iss. 1, pp. e1012456-e1012456
Open Access
Ascertainment of vaccination status by self‐report versus source documentation: Impact on measuring COVID‐19 vaccine effectiveness
Meagan Stephenson, Samantha M. Olson, Wesley H. Self, et al.
Influenza and Other Respiratory Viruses (2022) Vol. 16, Iss. 6, pp. 1101-1111
Open Access | Times Cited: 24
Clinical Characteristics of Mild Patients with Breakthrough Infection of Omicron Variant in China after Relaxing the Dynamic Zero COVID-19 Policy
Yingyu He, Fang Zhang, Yan Liu, et al.
Vaccines (2023) Vol. 11, Iss. 5, pp. 968-968
Open Access | Times Cited: 14
Accuracy of Self-Reported COVID-19 Vaccination Status Compared With a Public Health Vaccination Registry in Québec: Observational Diagnostic Study
Patrick Archambault, Rhonda J. Rosychuk, Martyne Audet, et al.
JMIR Public Health and Surveillance (2023) Vol. 9, pp. e44465-e44465
Open Access | Times Cited: 14
Durability of protection from original monovalent and bivalent COVID-19 vaccines against COVID-19-associated hospitalization and severe in-hospital outcomes among adults in the United States — September 2022–August 2023
Jennifer DeCuir, Diya Surie, Yuwei Zhu, et al.
medRxiv (Cold Spring Harbor Laboratory) (2024)
Open Access | Times Cited: 4
Effectiveness of the BNT162b2 (Pfizer-BioNTech) Vaccine in Children and Adolescents: A Systematic Review and Meta-Analysis
Jewel Maria Sabu, Izza Zahid, Namitha Jacob, et al.
Vaccines (2022) Vol. 10, Iss. 11, pp. 1880-1880
Open Access | Times Cited: 20
Short-Term Side Effects and SARS-CoV-2 Infection after COVID-19 Pfizer–BioNTech Vaccine in Children Aged 5–11 Years: An Italian Real-World Study
Martina Capponi, Federica Pulvirenti, Bianca Laura Cinicola, et al.
Vaccines (2022) Vol. 10, Iss. 7, pp. 1056-1056
Open Access | Times Cited: 18
Effectiveness of Booster Doses of Monovalent mRNA COVID-19 Vaccine Against Symptomatic Severe Acute Respiratory Syndrome Coronavirus 2 Infection in Children, Adolescents, and Adults During Omicron Subvariant BA.2/BA.2.12.1 and BA.4/BA.5 Predominant Periods
Allison Avrich Ciesla, Ryan E. Wiegand, Zachary Smith, et al.
Open Forum Infectious Diseases (2023) Vol. 10, Iss. 5
Open Access | Times Cited: 10
Risk factors affecting COVID-19 vaccine effectiveness identified from 290 cross-country observational studies until February 2022: a meta-analysis and meta-regression
Marek Petráš, Roman Máčalík, D Janovská, et al.
BMC Medicine (2022) Vol. 20, Iss. 1
Open Access | Times Cited: 16
A Comprehensive Review on the Current Vaccines and Their Efficacies to Combat SARS-CoV-2 Variants
Ali A. Rabaan, Abbas Al Mutair, Khalid Hajissa, et al.
Vaccines (2022) Vol. 10, Iss. 10, pp. 1655-1655
Open Access | Times Cited: 15
Knowledge on Parental Hesitancy toward COVID-19 Vaccination of Children 5–11 Years Old
Susanna Esposito, Cristiano Rosafio, S Partesotti, et al.
Vaccines (2023) Vol. 11, Iss. 3, pp. 587-587
Open Access | Times Cited: 8
Relative vaccine effectiveness of mRNA COVID-19 boosters in people aged at least 75 years during the spring-summer (monovalent vaccine) and autumn-winter (bivalent vaccine) booster campaigns: a prospective test negative case–control study, United Kingdom, 2022
Anastasia Chatzilena, Catherine Hyams, Robert Challen, et al.
Eurosurveillance (2023) Vol. 28, Iss. 48
Open Access | Times Cited: 8
Low antibody levels associated with significantly increased rate of SARS‐CoV‐2 infection in a highly vaccinated population from the US National Basketball Association
Caroline G. Tai, Miriam J. Haviland, Stephen M. Kissler, et al.
Journal of Medical Virology (2024) Vol. 96, Iss. 3
Closed Access | Times Cited: 2
Prior infections and effectiveness of SARS-CoV-2 vaccine in test-negative studies: A systematic review and meta-analysis
Tim K. Tsang, Sheena G. Sullivan, Xiaotong Huang, et al.
American Journal of Epidemiology (2024) Vol. 193, Iss. 12, pp. 1868-1881
Open Access | Times Cited: 2
Effectiveness of Original Monovalent and Bivalent COVID‐19 Vaccines Against COVID‐19‐Associated Hospitalization and Severe In‐Hospital Outcomes Among Adults in the United States, September 2022–August 2023
Jennifer DeCuir, Diya Surie, Yuwei Zhu, et al.
Influenza and Other Respiratory Viruses (2024) Vol. 18, Iss. 11
Open Access | Times Cited: 2
Bias and negative values of COVID-19 vaccine effectiveness estimates from a test-negative design without controlling for prior SARS-CoV-2 infection
Ryan E. Wiegand, Bruce Fireman, Morgan Najdowski, et al.
Nature Communications (2024) Vol. 15, Iss. 1
Open Access | Times Cited: 2
Page 1 - Next Page

Scroll to top